Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
Henry I. Bussey, Pharm.D., FCCP
Senior Editor & President, Board of Directors
Dr. Bussey was selected in 2008 to receive the three-year GSK Distinguished Scholar in Thrombosis Award for his work to incorporate patient self-testing and online management into a better anticoagulation management system. This competitive award is provided by the Chest Foundation of the American College of Chest Physicians. Dr. Bussey served for a decade on the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy and was recently appointed to the Scientific Advisory Board of the North American Thrombosis Forum (NATF). He is a Fellow of the American College of Clinical Pharmacy and the American College of Chest Physicians. His research is clinically focused and was instrumental in the adoption of the INR for warfarin monitoring in North America. Dr. Bussey was a faculty member in the College of Pharmacy at the University of Texas at Austin for more than 25 years, but he retired from that position in August, 2011 in order to devote more time and effort to other activities as co-founder, president, and senior editor of ClotCare; a consultant to Genesis Advanced Technologies on the development of the ClotFree system for online anticoagulation management; and president of Genesis Clinical Research in San Antonio, TX. He has over 100 publications, is on the editorial board for Pharmacotherapy, and is a reviewer for several pharmacy and medical journals. Dr. Bussey obtained his B.S. in Pharmacy from the University of Georgia and his Pharm.D. (with a concurrent clinical pharmacy residency in Internal Medicine) from the University of Texas at Austin and the University of Texas Health Science Center in San Antonio. Dr. Bussey served recently on advisory boards for Canyon Pharmaceuticals, Ortho-McNeil, and Boehringer-Ingelheim; has received research support from Roche Diagnostics, Merck, and Novartis; and is not on the speakers' bureau of any pharmaceutical company.
Editorial Board Members
-
Henry I. Bussey, Pharm.D., FCCP -- San Antonio, TX
-
Marie Bussey, BBA, BS -- San Antonio, TX
-
Mary Amato, Pharm.D., MPH -- Boston, MA
-
Jack E. Ansell, M.D. -- New York, NY
-
William E. Dager, Pharm.D., FCSHP -- Sacramento, CA
-
Susan C. Fagan, Pharm.D., BCPS, FCCP -- Augusta, GA
-
Samuel Z. Goldhaber, M.D. -- Boston, MA
-
James B. Groce III, Pharm.D., CACP -- Greensboro, NC
-
Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA -- W. Palm Beach, FL
-
David W. Hawkins, Pharm.D. -- Sacramento, CA
-
Elaine M. Hylek, MD, MPH -- Boston, MA
-
Roger M. Lyons, MD, FACP -- San Antonio, TX
-
Edith A. Nutescu, Pharm.D. -- Chicago, IL
-
Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) -- Philadelphia, PA
-
Alex C. Spyropoulos, MD, FACP, FCCP -- Rochester, NY
-
Victor F. Tapson, M.D. -- Durham, NC
-
Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC -- Hamilton, Ontario, Canada
-
Robert T. Weibert, Pharm.D. -- San Diego, CA
-
Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP -- Seattle, WA
Return to Editorial Board main page
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|